Eli Lilly Expands Pet Vaccines Portfolio With Boehringer Acquisition
Eli Lilly shares had a bit of a boost on Wednesday after it was announced that one of its subsidiaries would be acquiring Boehringer Ingelheim Vetmedica.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 194
Trinity Biotech Shares in Freefall After Withdrawing FDA Submission
Trinity Biotech PLC (NASDAQ: TRIB) is watching its shares get halved on Tuesday after the company announced that it would withdraw one of its submissions to the U.S. Food and Drug Administration. Specifically, the…
US Cities Where the Fewest Residents Lack Health Insurance
The Affordable Care Act (aka, Obamacare) is perhaps the signature piece of legacy legislation in President Obama's nearly completed two terms in the White House. In these cities, the uninsured rates are lowest.
Summit Therapeutics Skyrockets on Sarepta Deal
Shares of Summit Therapeutics more than doubled on Tuesday after it was announced that it would be entering into a licensing deal with Sarepta Therapeutics.
Key FDA Decisions and Trial Results Expected in October
24/7 Wall St. has collected several big FDA decisions and mid-stage to late-stage trials that should be announced in October.
Jaguar Animal Health Stumbles on Secondary Offering
Jaguar Animal Health Inc. (NASDAQ: JAGX) filed a Form S-1 with the U.S. Securities and Exchange Commission (SEC) regarding a secondary offering. The expected price of the 4.32 million shares is $1.20 per share. The…
Top 6 Biopharma Gainers of the Past Week
Over the past week, a few biotech companies made absolutely massive runs. The companies 24/7 Wall St. has picked stood out from the rest with at least 25% gains.
SEC Issues Charges Over Biotech Insider Activity
The SEC has charged the former senior director of regulatory affairs for Puma Biotechnology with insider trading ahead of the company’s news announcements about its drug to treat breast cancer.
SunTrust Has Large Cap Dividend Pharma Stocks to Buy Now
Any of these three top pharmaceutical companies makes an outstanding addition to more conservative portfolios. They are also far less volatile and act better than biotechs if the market gets dicey.
Catabasis Skyrockets on Sarepta Partnership
Catabasis Pharmaceuticals shares skyrocketed on Thursday following an announcement that it would be partnering with Sarepta Therapeutics for a joint research collaboration.
2 Animal Health Stocks Still Look Attractive for Investors
If there is one trend that has worked in America, it is the trend of betting on the public taking care of their pets. Now Merrill Lynch has issued a report on the state…
Alcobra Tumbles on FDA Clinical Hold
Alcobra saw its shares get halved on Thursday after the U.S. Food and Drug Administration (FDA) placed a clinical hold on its late-stage trial.
Mylan Woes Pushing Stock Back Toward 52-Week Low
Mylan just has been unable to recover from its EpiPen pricing hike issue. Thursday's additional weakness was tied to a late Wednesday report from U.S. federal health regulators.
Genocea Biosciences Posts Positive Herpes Trial Results
Shares of Genocea Biosciences saw a handy gain early on Thursday on positive news from its genital herpes trial, but investor enthusiasm was short lived.
Intra-Cellular Stumbles Over Late-Stage Results
Intra-Cellular Therapies saw its shares absolutely crash on Thursday following the results from its late-stage schizophrenia trial.